吸入一酸化窒素送達システムの世界市場

吸入一酸化窒素送達システムの世界市場は2030年までに8億6,480万米ドルに達する見込み

2024年に6億9,970万米ドルと推定される吸入一酸化窒素送達システムの世界市場は、2024～2030年の分析期間においてCAGR 3.6%で成長し、2030年には8億6,480万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである小児科は、CAGR 4.3%を記録し、分析期間終了時には6億1,030万米ドルに達すると予測されています。成人セグメントの成長率は、分析期間中CAGR 2.0%と推定されます。

米国市場は1億9,060万米ドルと推定、中国はCAGR6.8%で成長予測

米国の吸入一酸化窒素送達システム市場は、2024年に1億9,060万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.8%として、2030年までに1億7,460万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4%と2.8%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の吸入一酸化窒素送達システム市場- 主要動向と促進要因まとめ

吸入一酸化窒素送達システムの需要を促進しているものは何か？

吸入一酸化窒素（iNO）デリバリーシステム市場は、呼吸療法やクリティカルケアにおける用途の増加により、著しい成長を遂げています。吸入一酸化窒素は選択的肺血管拡張薬として、特に新生児遷延性肺高血圧症（PPHN）、急性呼吸窮迫症候群（ARDS）、低酸素性呼吸不全などの治療に広く使用されています。新生児呼吸器疾患の発生率の増加と早産児数の増加が、新生児集中治療室（NICU）における高度なiNO供給システムの需要を促進しています。さらに、成人の重症治療環境、特に重度の呼吸困難や肺高血圧症の患者に対するiNO療法の使用は、市場範囲をさらに拡大しています。

市場成長を促進するもう1つの重要な要因は、体外膜酸素療法（ECMO）におけるiNO療法の採用が増加していることです。ECMO療法が重症心肺不全患者に対する標準的な介入となるにつれ、ECMO回路へのiNO送達システムの統合が牽引力を増しています。吸入一酸化窒素には酸素化を改善し肺血管抵抗を減少させる作用があるため、ECMO患者における貴重な補助療法となります。さらに、慢性閉塞性肺疾患（COPD）、間質性肺疾患、COVID-19誘発性呼吸器合併症などの症状に対するiNOの潜在的応用に関する調査が進行中であることも、革新的なiNO送達技術に対する需要の拡大に寄与しています。

技術革新はどのように吸入一酸化窒素送達を強化しているのか？

iNO送達システムの進化は、治療精度、携帯性、患者の安全性の向上を目指した重要な技術的進歩によって形作られています。この分野における最も注目すべき技術革新のひとつは、コンパクトで携帯可能な一酸化窒素投与装置の開発です。従来の病院ベースのiNOシステムは、外来や在宅ケアの現場での治療投与を可能にする軽量で携帯可能なソリューションによって補完されつつあります。これらの携帯型装置は、肺動脈性肺高血圧症（PAH）や線維化肺疾患などの症状で長期的なiNO療法を必要とする小児・成人患者にとって特に有益です。分散型治療と在宅治療ソリューションへのシフトは、携帯型iNO送達技術のさらなる進歩を促進すると予想されます。

iNO供給におけるもう一つの変革的動向は、スマートモニタリングと自動化機能の統合です。次世代のiNOデバイスは、リアルタイム酸素化モニタリング、自動投与量調整、患者固有のニーズに基づいて一酸化窒素投与を最適化する閉ループ制御システムを備えています。これらのインテリジェント・システムは、二酸化窒素（NO2）毒性のリスクを低減し、より安全で効果的な治療を保証します。さらに、遠隔患者モニタリング（RPM）やクラウドベースのデータ解析を含むデジタルヘルス技術がiNO送達システムに組み込まれ、臨床医が治療の進捗状況を追跡し、治療パラメーターを遠隔で調整できるようになっています。これらの進歩は、臨床ワークフローを合理化し、病院の負担を軽減する一方で、患者の転帰を向上させています。

従来の用途を超えたiNO療法の用途拡大とは？

吸入一酸化窒素療法は主に新生児や重症患者を対象とした治療で使用されてきたが、その用途は新たな治療領域にも広がりつつあり、さらなる市場機会を引き出しています。新たに注目されている分野の一つは、肺移植に伴う肺合併症の治療への一酸化窒素の使用です。研究では、一酸化窒素が虚血再灌流障害を軽減し、移植片機能を改善し、移植後の肺高血圧症のリスクを低下させることが示唆されています。肺移植手術が世界中で増加するにつれて、周術期および移植後のケアにおけるiNO療法の需要は増大すると予想されます。

もう一つの有望な用途は、心臓病学、特に駆出率が維持された心不全（HFpEF）と右室機能不全の治療におけるiNO療法の潜在的使用です。一酸化窒素の血管拡張作用は右心機能と肺循環を改善し、肺高血圧を有する心不全患者にとって貴重な治療選択肢となります。さらに、現在進行中の臨床試験では、高地肺水腫（HAPE）、慢性血栓塞栓性肺高血圧症（CTEPH）、術後の肺合併症の管理におけるiNOの有効性が評価されています。これらの新たな適応症は、次世代iNO送達システムの開発と商業化のための新たな道筋を作っています。

iNO送達システム市場の将来を形成する主な成長促進要因は何か？

吸入一酸化窒素送達システム市場の成長は、技術の進歩、治療適応の拡大、呼吸器疾患や心血管疾患の有病率の増加など、いくつかの要因によってもたらされます。主な促進要因の1つは、新生児肺疾患の発生率の上昇とNICUにおけるiNO療法の採用拡大です。早産率が上昇する中、ヘルスケアプロバイダーは新生児の呼吸予後を改善し、長期合併症のリスクを低減するため、先進的なiNO送達システムに投資しています。

市場拡大に拍車をかけているもう一つの主な要因は、急性および慢性呼吸器疾患におけるiNO療法の需要の増加です。COVID-19の大流行は、重症呼吸不全患者の酸素化改善における吸入一酸化窒素の潜在的役割を浮き彫りにし、iNO送達技術に対する研究関心の高まりと投資につながりました。さらに、肺高血圧症や間質性肺疾患に対する認識の高まりは、iNO療法の有効性と利用しやすさを向上させるために、製薬会社が新しい製剤やデバイスの革新を探求する原動力となっています。

規制の進展や業界間の協力関係も市場の成長を形成しています。米国食品医薬品局（FDA）や欧州の規制機関は、新規のiNOデリバリーシステムの開発を積極的に支援しており、安全性と性能を改善した次世代デバイスの導入につながっています。さらに、医療機器会社、製薬会社、研究機関の戦略的提携により、革新的なiNO送達ソリューションの商業化が加速しています。このような要因の収束により、吸入一酸化窒素送達システム市場は、技術革新、臨床応用の拡大、救命呼吸療法への患者アクセスの改善に重点を置きながら、持続的成長を遂げるものと位置付けられています。

セグメント

製品タイプ（小児用、成人用）;製品（ディスポーザブル、システム）;用途（低酸素性呼吸不全、急性低酸素性呼吸不全、その他）;最終用途（病院、外来手術センター、クリニック）

調査対象企業の例

• Air Liquide Healthcare
• Bellerophon Therapeutics
• Beyond Air, Inc.
• BioLum Sciences
• Breeze Technologies
• Circassia Pharmaceuticals
• Cyclerion Therapeutics
• Getinge AB
• International Biomedical
• Linde plc
• Mallinckrodt Pharmaceuticals
• Medtronic plc
• NIOX Group plc
• NOxBOX Ltd.
• NU-MED Plus, Inc.
• Philips Healthcare
• SLE Ltd.
• SoundHealth
• VERO Biotech
• Zylo Therapeutics

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Inhaled Nitric Oxide Delivery Systems Market to Reach US$864.8 Million by 2030

The global market for Inhaled Nitric Oxide Delivery Systems estimated at US$699.7 Million in the year 2024, is expected to reach US$864.8 Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Pediatric, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$610.3 Million by the end of the analysis period. Growth in the Adult segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$190.6 Million While China is Forecast to Grow at 6.8% CAGR

The Inhaled Nitric Oxide Delivery Systems market in the U.S. is estimated at US$190.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$174.6 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Inhaled Nitric Oxide Delivery Systems Market - Key Trends & Drivers Summarized

What Is Propelling the Demand for Inhaled Nitric Oxide Delivery Systems?

The market for inhaled nitric oxide (iNO) delivery systems is witnessing significant growth, driven by increasing applications in respiratory therapy and critical care. Inhaled nitric oxide is widely used as a selective pulmonary vasodilator, particularly in treating conditions such as persistent pulmonary hypertension of the newborn (PPHN), acute respiratory distress syndrome (ARDS), and hypoxic respiratory failure. The growing incidence of neonatal respiratory disorders and the rising number of preterm births have propelled the demand for advanced iNO delivery systems in neonatal intensive care units (NICUs). Additionally, the use of iNO therapy in adult critical care settings, particularly for patients with severe respiratory distress and pulmonary hypertension, has further expanded its market scope.

Another crucial factor driving market growth is the increasing adoption of iNO therapy in extracorporeal membrane oxygenation (ECMO) procedures. As ECMO therapy becomes a standard intervention for patients with severe cardiopulmonary failure, the integration of iNO delivery systems into ECMO circuits is gaining traction. The ability of inhaled nitric oxide to improve oxygenation and reduce pulmonary vascular resistance makes it a valuable adjunct therapy in ECMO-supported patients. Moreover, ongoing research into the potential applications of iNO for conditions such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and COVID-19-induced respiratory complications is contributing to the growing demand for innovative iNO delivery technologies.

How Are Technological Innovations Enhancing Inhaled Nitric Oxide Delivery?

The evolution of iNO delivery systems is being shaped by significant technological advancements aimed at improving treatment precision, portability, and patient safety. One of the most notable innovations in this space is the development of compact and portable nitric oxide delivery devices. Traditional hospital-based iNO systems are being complemented by lightweight, mobile solutions that enable therapy administration in ambulatory and homecare settings. These portable devices are particularly beneficial for pediatric and adult patients requiring long-term iNO therapy for conditions such as pulmonary arterial hypertension (PAH) and fibrotic lung diseases. The shift towards decentralized care and home-based treatment solutions is expected to drive further advancements in portable iNO delivery technologies.

Another transformative trend in iNO delivery is the integration of smart monitoring and automation features. Next-generation iNO devices are equipped with real-time oxygenation monitoring, automated dose adjustment, and closed-loop control systems that optimize nitric oxide administration based on patient-specific needs. These intelligent systems reduce the risk of nitrogen dioxide (NO2) toxicity, ensuring safer and more effective therapy. Additionally, digital health technologies, including remote patient monitoring (RPM) and cloud-based data analytics, are being incorporated into iNO delivery systems, allowing clinicians to track treatment progress and adjust therapy parameters remotely. These advancements are enhancing patient outcomes while streamlining clinical workflows and reducing hospital burden.

What Are the Expanding Applications of iNO Therapy Beyond Traditional Uses?

While inhaled nitric oxide therapy has been primarily used in neonatal and critical care settings, its applications are expanding into new therapeutic areas, unlocking additional market opportunities. One emerging area of interest is the use of iNO for treating pulmonary complications associated with lung transplantation. Studies suggest that nitric oxide can reduce ischemia-reperfusion injury, improve graft function, and lower the risk of post-transplant pulmonary hypertension. As lung transplantation procedures increase worldwide, the demand for iNO therapy in perioperative and post-transplant care is expected to grow.

Another promising application is the potential use of iNO therapy in cardiology, particularly in treating heart failure with preserved ejection fraction (HFpEF) and right ventricular dysfunction. Nitric oxide’s vasodilatory effects can improve right heart function and pulmonary circulation, making it a valuable therapeutic option for heart failure patients with pulmonary hypertension. Additionally, ongoing clinical trials are evaluating the effectiveness of iNO in managing high-altitude pulmonary edema (HAPE), chronic thromboembolic pulmonary hypertension (CTEPH), and post-operative pulmonary complications. These emerging indications are creating new pathways for the development and commercialization of next-generation iNO delivery systems.

What Are the Key Growth Drivers Shaping the Future of the iNO Delivery Systems Market?

The growth in the inhaled nitric oxide delivery systems market is driven by several factors, including technological advancements, expanding therapeutic indications, and the increasing prevalence of respiratory and cardiovascular disorders. One of the primary drivers is the rising incidence of neonatal pulmonary disorders and the growing adoption of iNO therapy in NICUs. With premature birth rates on the rise, healthcare providers are investing in advanced iNO delivery systems to improve neonatal respiratory outcomes and reduce the risk of long-term complications.

Another key factor fueling market expansion is the increasing demand for iNO therapy in acute and chronic respiratory diseases. The COVID-19 pandemic highlighted the potential role of inhaled nitric oxide in improving oxygenation in patients with severe respiratory failure, leading to heightened research interest and investment in iNO delivery technologies. Additionally, the growing awareness of pulmonary hypertension and interstitial lung diseases is driving pharmaceutical companies to explore new formulations and device innovations to enhance iNO therapy’s efficacy and accessibility.

Regulatory advancements and industry collaborations are also shaping market growth. The U.S. Food and Drug Administration (FDA) and European regulatory bodies are actively supporting the development of novel iNO delivery systems, leading to the introduction of next-generation devices with improved safety and performance features. Furthermore, strategic partnerships between medical device companies, pharmaceutical firms, and research institutions are accelerating the commercialization of innovative iNO delivery solutions. The convergence of these factors is positioning the inhaled nitric oxide delivery systems market for sustained growth, with a strong emphasis on technological innovation, expanded clinical applications, and improved patient access to life-saving respiratory therapies.

SCOPE OF STUDY:

The report analyzes the Inhaled Nitric Oxide Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Pediatric, Adult); Product (Disposables, System); Application (Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Air Liquide Healthcare
• Bellerophon Therapeutics
• Beyond Air, Inc.
• BioLum Sciences
• Breeze Technologies
• Circassia Pharmaceuticals
• Cyclerion Therapeutics
• Getinge AB
• International Biomedical
• Linde plc
• Mallinckrodt Pharmaceuticals
• Medtronic plc
• NIOX Group plc
• NOxBOX Ltd.
• NU-MED Plus, Inc.
• Philips Healthcare
• SLE Ltd.
• SoundHealth
• VERO Biotech
• Zylo Therapeutics

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Inhaled Nitric Oxide Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increased Adoption of Inhaled Nitric Oxide in Neonatal Respiratory Care Drives Market for Delivery Systems
  • Rising Incidence of Pulmonary Hypertension and ARDS in Adults Strengthens Clinical Use of iNO Devices
  • Expansion of iNO Use in Cardiac Surgery and Organ Transplantation Enhances Cross-Disciplinary Demand
  • FDA Approvals for Portable and Home-Based iNO Systems Spur Demand for Mobile and Lightweight Designs
  • Technological Innovation in Real-Time Monitoring and Dosing Control Drives Product Differentiation
  • Growth of Emergency and Critical Care Infrastructure in Emerging Markets Expands Access to iNO Therapies
  • OEM Partnerships With Hospitals and Respiratory Therapists Enhance Adoption of Next-Gen iNO Platforms
  • Surge in Clinical Trials Exploring iNO for COVID-19 and Related Respiratory Complications Supports Market Momentum
  • Improved Safety Features and Cylinder-Free Devices Reduce Operational Risks and Support Broader Use
  • Global Regulatory Harmonization and Expanded Indications Strengthen Business Case for Inhaled Nitric Oxide Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Inhaled Nitric Oxide Delivery Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Inhaled Nitric Oxide Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Disposables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Disposables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hypoxic Respiratory Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hypoxic Respiratory Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hypoxic Respiratory Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Acute Hypoxemic Respiratory Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Acute Hypoxemic Respiratory Failure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Acute Hypoxemic Respiratory Failure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• JAPAN
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• CHINA
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• EUROPE
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• FRANCE
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• GERMANY
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 197: Australia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Australia Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Australia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• INDIA
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 209: India Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: India Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: India 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 212: India Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 221: South Korea Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: South Korea Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: South Korea 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Argentina Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Argentina 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Brazil Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Brazil 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Mexico Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Mexico 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 309: Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Iran Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Iran 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Israel Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Israel 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Saudi Arabia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: UAE Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: UAE 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030
• AFRICA
  • Inhaled Nitric Oxide Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Africa Historic Review for Inhaled Nitric Oxide Delivery Systems by Type - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Africa 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Type - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Inhaled Nitric Oxide Delivery Systems by End-Use - Clinics, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Clinics, Hospitals and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Inhaled Nitric Oxide Delivery Systems by Product - Disposables and System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Product - Percentage Breakdown of Value Sales for Disposables and System for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Inhaled Nitric Oxide Delivery Systems by Application - Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Inhaled Nitric Oxide Delivery Systems by Application - Percentage Breakdown of Value Sales for Hypoxic Respiratory Failure, Acute Hypoxemic Respiratory Failure and Others for the Years 2015, 2025 & 2030

IV. COMPETITION